Castleark Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Castleark Management’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-2,170	Closed	-$215K	–	408
2019 Q2	$215K	Sell	2,170 -1,130	-34%	-$108K	0.01%	330
2019 Q1	$364K	Sell	3,300 -980	-23%	-$102K	0.01%	316
2018 Q4	$394K	Hold	4,280	–	–	0.02%	312
2018 Q3	$472K	Buy	4,280 +2,270	+113%	+$236K	0.01%	324
2018 Q2	$188K	Sell	2,010 -99,538	-98%	-$8.57M	0.01%	348
2018 Q1	$8.42M	Sell	101,548 -105,368	-51%	-$9.36M	0.27%	119
2017 Q4	$18.8M	Sell	206,916 -930	-0.4%	-$77.4K	0.57%	45
2017 Q3	$15.8M	Sell	207,846 -33,470	-14%	-$2.53M	0.5%	53
2017 Q2	$18.1M	Sell	241,316 -8,679	-3%	-$602K	0.59%	43
2017 Q1	$16.3M	Sell	249,995 -23,560	-9%	-$1.39M	0.51%	48
2016 Q4	$15.1M	Buy	273,555 +5,110	+2%	+$280K	0.48%	49
2016 Q3	$15.2M	Buy	+268,445	New	+$13.2M	0.46%	50

Other funds holding PRAH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Castleark Management's PRAH Position: Q3 2019 in Review

Castleark Management sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2019, closing a stake of 2,170 shares — an estimated $215K sold.

Castleark Management first reported a position in PRAH in Q3 2016 and held it in 12 quarters. The position peaked at $18.8M in Q4 2017. 329 funds tracked by Wall St. Rank hold PRAH as of Q3 2019.

Castleark Management reported no remaining PRA Health Sciences, Inc. position as of Q3 2019 after selling out during the quarter.
Castleark Management sold 2,170 PRA Health Sciences, Inc. shares in Q3 2019, an estimated $215K.
Castleark Management first reported a position in PRA Health Sciences, Inc. in Q3 2016 and held it in 12 quarters.
Castleark Management's PRA Health Sciences, Inc. position peaked at $18.8M in Q4 2017.
329 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2019.

Based on Castleark Management's 13F filing for Q3 2019, filed 15 Nov 2019.